Impact of prescription drug monitoring programs (PDMPs) on opioid utilization among Medicare beneficiaries in 10 US States.
Patience MoyoLinda Simoni-WastilaBeth Ann GriffinEberechukwu OnukwughaDonna HarringtonG Caleb AlexanderFrancis PalumboPublished in: Addiction (Abingdon, England) (2017)
Prescription drug monitoring programs (PDMPs) are associated with reductions in opioid use, measured by volume, among disabled and older adult Medicare beneficiaries in the United States compared with states that do not have PDMPs. PDMP impact on daily doses and daily prescriptions varied by reason for eligibility and plan type. These findings cannot be generalized beyond the 10 US states studied.